Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.

Vargas-Ayala RC, Jay A, Manara F, Maroui MA, Hernandez-Vargas H, Diederichs A, Robitaille A, Sirand C, Ceraolo MG, Romero-Medina MC, Cros MP, Cuenin C, Durand G, Le Calvez-Kelm F, Mundo L, Leoncini L, Manet E, Herceg Z, Gruffat H, Accardi R.

J Virol. 2019 Jun 14;93(13). pii: e00273-19. doi: 10.1128/JVI.00273-19. Print 2019 Jul 1.

PMID:
30996097
2.

Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.

Granai M, Ambrosio MR, Akarca A, Mundo L, Vergoni F, Santi R, Mancini V, di Stefano G, Amato T, Bellan C, Puccini B, Sorrentino E, Naresh KN, Leoncini L, Marafioti T, Lazzi S.

Haematologica. 2019 Jun;104(6):e269-e273. doi: 10.3324/haematol.2018.215053. Epub 2019 Mar 7. No abstract available.

3.

p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.

Patrussi L, Capitani N, Ulivieri C, Manganaro N, Granai M, Cattaneo F, Kabanova A, Mundo L, Gobessi S, Frezzato F, Visentin A, Finetti F, Pelicci PG, D'Elios MM, Trentin L, Semenzato G, Leoncini L, Efremov DG, Baldari CT.

Haematologica. 2019 Feb 28. pii: haematol.2018.209981. doi: 10.3324/haematol.2018.209981. [Epub ahead of print]

4.

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.

Wagener R, Seufert J, Raimondi F, Bens S, Kleinheinz K, Nagel I, Altmüller J, Thiele H, Hübschmann D, Kohler CW, Nürnberg P, Au-Yeung R, Burkhardt B, Horn H, Leoncini L, Jaffe ES, Ott G, Rymkiewicz G, Schlesner M, Russell RB, Klapper W, Siebert R.

Blood. 2019 Feb 28;133(9):962-966. doi: 10.1182/blood-2018-07-864025. Epub 2018 Dec 19.

PMID:
30567752
5.

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.

Lo Bello G, Akarca AU, Ambrosio MR, Agostinelli C, Molina-Kirsch H, Ramsay A, Rodriguez-Justo M, Pugh M, Zhao S, DeLisser M, Sabattini E, Dojcinov S, Pileri SA, Natkunam Y, Leoncini L, Marafioti T.

Virchows Arch. 2018 Dec;473(6):749-757. doi: 10.1007/s00428-018-2434-x. Epub 2018 Aug 27.

6.

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.

Ambrosio MR, Lazzi S, Bello GL, Santi R, Porro LD, de Santi MM, Guazzo R, Mundo L, Rigacci L, Kovalchuck S, Onyango N, Fabbri A, Cencini E, Zinzani PL, Zaja F, Angrilli F, Stelitano C, Cabras MG, Spataro G, Bob R, Menter T, Granai M, Cevenini G, Naresh KN, Stein H, Sabattini E, Leoncini L.

Haematologica. 2019 Jan;104(1):e25-e28. doi: 10.3324/haematol.2018.195958. Epub 2018 Jun 28. No abstract available.

7.

Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas.

Piccaluga PP, Weber A, Ambrosio MR, Ahmed Y, Leoncini L.

Front Microbiol. 2018 Jun 8;9:1233. doi: 10.3389/fmicb.2018.01233. eCollection 2018. Review.

8.

Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas.

Navari M, Etebari M, Ibrahimi M, Leoncini L, Piccaluga PP.

Int J Mol Sci. 2018 Apr 12;19(4). pii: E1168. doi: 10.3390/ijms19041168. Review.

9.

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma.

Ambrosio MR, Mundo L, Gazaneo S, Picciolini M, Vara PS, Sayed S, Ginori A, Lo Bello G, Del Porro L, Navari M, Ascani S, Yonis A, Leoncini L, Piccaluga PP, Lazzi S.

Oncotarget. 2017 Oct 31;8(64):107356-107373. doi: 10.18632/oncotarget.22219. eCollection 2017 Dec 8.

10.

Preferential Usage of Specific Immunoglobulin Heavy Chain Variable Region Genes With Unmutated Profile and Advanced Stage at Presentation Are Common Features in Patients With Chronic Lymphocytic Leukemia From Senegal.

Amato T, Sall A, Dièye TN, Gozzetti A, Iacono M, Ambrosio MR, Granai M, Somma S, Diop S, Touré AO, May E, Gattiollat CH, Wiels J, Ahmed Y, Raphael M, Leoncini L, Bellan C, Piccaluga PP.

Am J Clin Pathol. 2017 Nov 20;148(6):545-554. doi: 10.1093/ajcp/aqx105.

PMID:
29165569
11.

How in-depth histological look may allow challenging diagnosis: The case of a primary in situ mantle cell neoplasm of the appendix.

Ambrosio MR, Granai M, Lo Bello G, Cirami M, Mundo L, Leoncini L, Lazzi S.

Hematol Oncol. 2018 Feb;36(1):376-378. doi: 10.1002/hon.2418. Epub 2017 Apr 9. No abstract available.

PMID:
28393378
12.

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases.

Mundo L, Ambrosio MR, Picciolini M, Lo Bello G, Gazaneo S, Del Porro L, Lazzi S, Navari M, Onyango N, Granai M, Bellan C, De Falco G, Gibellini D, Piccaluga PP, Leoncini L.

Front Microbiol. 2017 Mar 1;8:229. doi: 10.3389/fmicb.2017.00229. eCollection 2017.

13.

The surgical pathology laboratory in Mwanza, Tanzania: a survey on the reproducibility of diagnoses after the first years of autonomous activity.

Tumino R, Rambau PF, Callea F, Leoncini L, Monaco R, Kahima J, Stracca Pansa V, Viberti L, Amadori D, Giovenali P, Mteta KA.

Infect Agent Cancer. 2017 Jan 21;12:6. doi: 10.1186/s13027-017-0115-z. eCollection 2017.

14.

Optimal Minimal Panels of Immunohistochemistry for Diagnosis of B-Cell Lymphoma for Application in Countries With Limited Resources and for Triaging Cases Before Referral to Specialist Centers.

Disanto MG, Ambrosio MR, Rocca BJ, Ibrahim HA, Leoncini L, Naresh KN.

Am J Clin Pathol. 2016 May;145(5):687-95. doi: 10.1093/ajcp/aqw060.

PMID:
27247372
15.

The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre?

Ambrosio MR, Lo Bello G, Amato T, Lazzi S, Piccaluga PP, Leoncini L, Bellan C.

Histopathology. 2016 Nov;69(5):885-886. doi: 10.1111/his.12997. Epub 2016 Jul 15. No abstract available.

PMID:
27206498
16.

Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.

Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A, De Falco G, Ambrosio MR, Mourmouras V, Ogwang M, Calbi V, Rabadan R, Hummel M, Pileri S, Leoncini L, Bellan C.

Am J Clin Pathol. 2016 Jan;145(1):116-27. doi: 10.1093/ajcp/aqv011.

17.

Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry.

Stasi C, Leoncini L, Biagini MR, Arena U, Madiai S, Laffi G, Marra F, Milani S.

Dig Liver Dis. 2016 Mar;48(3):298-301. doi: 10.1016/j.dld.2015.10.024. Epub 2015 Nov 4.

PMID:
26632448
18.

A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.

Ambrosio MR, Rocca BJ, Ginori A, Mourmouras V, Amato T, Vindigni C, Lazzi S, Leoncini L.

Am J Clin Pathol. 2015 Nov;144(5):817-22. doi: 10.1309/AJCP2G0VKTKPNPRR.

PMID:
26486748
19.

Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.

Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, Zairis S, Gazaneo S, De Falco G, Lazzi S, Bellan C, Rocca BJ, Amato T, Marasco E, Etebari M, Ogwang M, Calbi V, Ndede I, Patel K, Chumba D, Piccaluga PP, Pileri S, Leoncini L, Rabadan R.

PLoS Pathog. 2015 Oct 15;11(10):e1005158. doi: 10.1371/journal.ppat.1005158. eCollection 2015 Oct.

20.

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.

De Falco G, Ambrosio MR, Fuligni F, Onnis A, Bellan C, Rocca BJ, Navari M, Etebari M, Mundo L, Gazaneo S, Facchetti F, Pileri SA, Leoncini L, Piccaluga PP.

BMC Cancer. 2015 Oct 9;15:668. doi: 10.1186/s12885-015-1661-7.

21.

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.

Piccaluga PP, Navari M, De Falco G, Ambrosio MR, Lazzi S, Fuligni F, Bellan C, Rossi M, Sapienza MR, Laginestra MA, Etebari M, Rogena EA, Tumwine L, Tripodo C, Gibellini D, Consiglio J, Croce CM, Pileri SA, Leoncini L.

Oncotarget. 2016 Jan 5;7(1):224-40. doi: 10.18632/oncotarget.4399.

22.

A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000-2011 at Kenyatta National Hospital, Kenya.

Rogena EA, Simbiri KO, De Falco G, Leoncini L, Ayers L, Nyagol J.

Infect Agent Cancer. 2015 Aug 24;10:28. doi: 10.1186/s13027-015-0021-1. eCollection 2015.

23.

Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity.

Ambrosio MR, De Falco G, Rocca BJ, Barone A, Amato T, Bellan C, Lazzi S, Leoncini L.

Virchows Arch. 2015 Oct;467(4):471-80. doi: 10.1007/s00428-015-1814-8. Epub 2015 Aug 19.

PMID:
26286813
24.

Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.

Cencini E, Fabbri A, Rigacci L, Lazzi S, Gini G, Cox MC, Mancuso S, Abruzzese E, Kovalchuk S, Goteri G, Di Napoli A, Bono R, Fratoni S, Di Lollo S, Bosi A, Leoncini L, Bocchia M.

Hematol Oncol. 2017 Mar;35(1):69-78. doi: 10.1002/hon.2249. Epub 2015 Aug 7.

PMID:
26251194
25.

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Navari M, Etebari M, De Falco G, Ambrosio MR, Gibellini D, Leoncini L, Piccaluga PP.

Front Microbiol. 2015 Jun 10;6:556. doi: 10.3389/fmicb.2015.00556. eCollection 2015.

26.

The tumor virus landscape of AIDS-related lymphomas.

Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E.

Blood. 2015 May 14;125(20):e14-22. doi: 10.1182/blood-2014-11-599951. Epub 2015 Mar 31.

27.

HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas.

Luzzi A, Morettini F, Gazaneo S, Mundo L, Onnis A, Mannucci S, Rogena EA, Bellan C, Leoncini L, De Falco G.

Infect Agent Cancer. 2014 Dec 9;9:41. doi: 10.1186/1750-9378-9-41. eCollection 2014.

28.

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.

Navari M, Fuligni F, Laginestra MA, Etebari M, Ambrosio MR, Sapienza MR, Rossi M, De Falco G, Gibellini D, Tripodo C, Pileri SA, Leoncini L, Piccaluga PP.

Front Microbiol. 2014 Dec 23;5:728. doi: 10.3389/fmicb.2014.00728. eCollection 2014.

29.

Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection.

Ambrosio MR, De Falco G, Gozzetti A, Rocca BJ, Amato T, Mourmouras V, Gazaneo S, Mundo L, Candi V, Piccaluga PP, Cusi MG, Leoncini L, Lazzi S.

Haematologica. 2014 Nov;99(11):e235-7. doi: 10.3324/haematol.2014.111872. Epub 2014 Sep 5. No abstract available.

30.

The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.

Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S, Piris MA, Leoncini L, De Falco G.

Infect Agent Cancer. 2014 Apr 14;9:12. doi: 10.1186/1750-9378-9-12. eCollection 2014.

31.

Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.

Mwololo A, Nyagol J, Rogena E, Ochuk W, Kimani M, Onyango N, Pacenti L, Santopietro R, Leoncini L, Mwanda W.

Infect Agent Cancer. 2014 Feb 26;9(1):7. doi: 10.1186/1750-9378-9-7.

32.

Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature.

Ambrosio MR, Mastrogiulio MG, Barone A, Rocca BJ, Gallo C, Lazzi S, Leoncini L, Bellan C.

Diagn Pathol. 2013 Jul 15;8:115. doi: 10.1186/1746-1596-8-115. Review.

33.

Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C.

Stasi C, Arena U, Zignego AL, Corti G, Monti M, Triboli E, Pellegrini E, Renzo S, Leoncini L, Marra F, Laffi G, Milani S, Pinzani M.

Dig Liver Dis. 2013 Oct;45(10):840-3. doi: 10.1016/j.dld.2013.03.023. Epub 2013 May 7.

PMID:
23660078
34.

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).

Passweg JR, Pabst T, Blum S, Bargetzi M, Li Q, Heim D, Stussi G, Gregor M, Leoncini L, Meyer-Monard S, Brauchli P, Chalandon Y; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2014 Jan;55(1):87-91. doi: 10.3109/10428194.2013.790540. Epub 2013 May 2.

PMID:
23547838
35.

Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.

Fernandez P, Solenthaler M, Spertini O, Quarroz S, Rovo A, Lovey PY, Leoncini L, Ruault-Jungblut S, D'Asaro M, Schaad O, Docquier M, Descombes P, Matthes T; Swiss Cytometry Society.

PLoS One. 2012;7(11):e49010. doi: 10.1371/journal.pone.0049010. Epub 2012 Nov 9.

36.

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

Giulino-Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, Rogena E, Pinkney KA, Rubin MA, Ribeiro RC, Yelensky R, Tam W, Stephens PJ, Cesarman E.

Blood. 2012 Dec 20;120(26):5181-4. doi: 10.1182/blood-2012-06-437624. Epub 2012 Oct 22.

37.

The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin.

Ambrosio MR, Piccaluga PP, Ponzoni M, Rocca BJ, Malagnino V, Onorati M, De Falco G, Calbi V, Ogwang M, Naresh KN, Pileri SA, Doglioni C, Leoncini L, Lazzi S.

PLoS One. 2012;7(8):e44315. doi: 10.1371/journal.pone.0044315. Epub 2012 Aug 31.

38.

Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma.

Onnis A, Navari M, Antonicelli G, Morettini F, Mannucci S, De Falco G, Vigorito E, Leoncini L.

Blood Cancer J. 2012 Aug 31;2:e84. doi: 10.1038/bcj.2012.29.

39.

Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

Ngoma T, Adde M, Durosinmi M, Githang'a J, Aken'Ova Y, Kaijage J, Adeodou O, Rajab J, Brown BJ, Leoncini L, Naresh K, Raphael M, Hurwitz N, Scanlan P, Rohatiner A, Venzon D, Magrath I.

Br J Haematol. 2012 Sep;158(6):749-62. doi: 10.1111/j.1365-2141.2012.09236.x. Epub 2012 Jul 30.

40.

Myeloid sarcoma and adenocarcinoma of the large bowel as collision tumors: a case report.

Rocca BJ, Ambrosio MR, Gozzetti A, Bocchia M, Leoncini L, Lazzi S.

Histol Histopathol. 2012 Jul;27(7):941-7. doi: 10.14670/HH-27.941.

PMID:
22648549
41.

Aggressive B-cell lymphomas.

Naresh KN, Magrath I, Raphael M, Leoncini L.

Adv Hematol. 2012;2012:604603. doi: 10.1155/2012/604603. Epub 2012 Mar 14. No abstract available.

42.

EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma.

Mannucci S, Luzzi A, Carugi A, Gozzetti A, Lazzi S, Malagnino V, Simmonds M, Cusi MG, Leoncini L, van den Bosch CA, De Falco G.

Adv Hematol. 2012;2012:149780. doi: 10.1155/2012/149780. Epub 2012 Apr 24.

43.

Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo.

Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH.

Oncogene. 2012 Dec 6;31(49):5081-9. doi: 10.1038/onc.2012.15. Epub 2012 Feb 6.

PMID:
22310293
44.

Patients with thymomas have an increased risk of developing additional malignancies: lack of immunological surveillance?

Granato F, Ambrosio MR, Spina D, Lazzi S, Rocca BJ, Voltolini L, Bongiolatti S, Luzzi L, Gotti G, Leoncini L, Tosi P.

Histopathology. 2012 Feb;60(3):437-42. doi: 10.1111/j.1365-2559.2011.04111.x.

PMID:
22276606
45.

A review of the trends of lymphomas in the equatorial belt of Africa.

Rogena EA, De Falco G, Schurfeld K, Leoncini L.

Hematol Oncol. 2011 Sep;29(3):111-5. doi: 10.1002/hon.977. Epub 2010 Nov 30. Review.

PMID:
21922507
46.

Infectious agents and lymphoma.

De Falco G, Rogena EA, Leoncini L.

Semin Diagn Pathol. 2011 May;28(2):178-87. Review.

PMID:
21842703
47.

Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.

Naresh KN, Ibrahim HA, Lazzi S, Rince P, Onorati M, Ambrosio MR, Bilhou-Nabera C, Amen F, Reid A, Mawanda M, Calbi V, Ogwang M, Rogena E, Byakika B, Sayed S, Moshi E, Mwakigonja A, Raphael M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):770-6. doi: 10.1111/j.1365-2141.2011.08771.x. Epub 2011 Jul 1.

PMID:
21718280
48.

Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

Naresh KN, Raphael M, Ayers L, Hurwitz N, Calbi V, Rogena E, Sayed S, Sherman O, Ibrahim HA, Lazzi S, Mourmouras V, Rince P, Githanga J, Byakika B, Moshi E, Durosinmi M, Olasode BJ, Oluwasola OA, Akang EE, Akenòva Y, Adde M, Magrath I, Leoncini L.

Br J Haematol. 2011 Sep;154(6):696-703. doi: 10.1111/j.1365-2141.2011.08772.x. Epub 2011 Jun 28. Review.

49.

Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models.

Di Maio G, Formichi P, Radi E, Bianchi S, Onnis A, Tarquini E, Leoncini L, Federico A.

J Cell Physiol. 2012 Apr;227(4):1771-5. doi: 10.1002/jcp.22901.

PMID:
21702048
50.

The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.

Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, De Falco G, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H.

Leukemia. 2011 Dec;25(12):1869-1876. doi: 10.1038/leu.2011.156. Epub 2011 Jun 24.

Supplemental Content

Loading ...
Support Center